TITLE

Script cost cuts asthma compliance

AUTHOR(S)
Goff, Ashleigh
PUB. DATE
June 2009
SOURCE
Pulse;6/17/2009, Vol. 69 Issue 21, p10
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a study on patients in Great Britain with asthma using preventive inhalers. Research has found that these patients do make poor potentially dangerous management decisions through skipping doses of inhaled steroids. Further, it has also appeared to strengthen the case for the single combined inhalers' use.
ACCESSION #
43154108

 

Related Articles

  • Inhaler switch warning. Praities, Nigel // Pulse;5/7/2008, Vol. 68 Issue 16, p13 

    The article reports on the study from the University of Aberdeen which assesses the effectiveness of combined inhalers for asthma in Great Britain. The study reveals that the combined inhalers improve compliance and reduce the use of other healthcare products. Researchers argue that primary care...

  • Salmeterol/fluticasone of value for mild-to-moderate asthma.  // PharmacoEconomics & Outcomes News;7/14/2007, Issue 532, p1 

    The article presents a study on salmeterol/fluticasone for treatment of mild to moderate asthma. According to the research, the most cost effective first-line controller therapy in mild to moderate asthma is salmeterol/fluticasone propionate compared to fluticasone inhaled corticosteroids...

  • Managing asthma: concordance with treatment. Knowles, Vikki // Practice Nurse;9/21/2007, Vol. 34 Issue 5, p35 

    The article discusses the management and treatment of asthma within the context of the nursing practice. The emphasis of this article is to promote concordance with preventive asthma treatment. To achieve this goal, nursing practitioners must help patients gain control over their asthma by...

  • Drug treatment. Brostoff, Jonathan; Gamlin, Linda // Asthma: The Complete Guide;1999, p318 

    This section relates the experiences of asthmatics in managing asthma attacks. In the late 1960s, the real revolution in asthma drugs started, and that just transformed John's life. He still was not well after it, but he was so much better. Rachel has had asthma since childhood. She is much...

  • Your asthma reliever inhaler: never leave home without it. Patel, Mitesh; Pilcher, Janine // Thorax;Dec2012, Vol. 67 Issue 12, p1119 

    The article presents a discussion on the need of carrying asthma reliever inhaler while going out of home using a case of a 25-year-old man with asthma who attended for routine out-patient review. Considering his condition, his current symptoms and recent inhaler use were discussed. In reviewing...

  • Inhaled corticosteroids and skin atrophy.  // WHO Drug Information;2004, Vol. 18 Issue 3, p213 

    The article reports that inhaled corticosteroids can cause skin atrophy. This adverse effect may be exacerbated by sun exposure, possibly via a cumulative mechanism. Inhaled corticosteroids have an essential role in the management of asthma. Inhalation allows high concentrations of...

  • Asthma scripts concern. Cressey, Daniel // Pulse;4/27/2006, Vol. 66 Issue 17, p8 

    The article reports on widespread worry and concern over the inappropriate prescribing of high-dose inhaled steroids for asthma patients in Great Britain. A study of drug prescribing practices by general practitioners (GP) has revealed that GPs prescribed high doses of inhaled steroids to more...

  • Beta-agonists can signal danger.  // GP: General Practitioner;8/19/2002, p43 

    Examines the danger of the excessive use of asthma inhalers in Great Britain. Association of inhaled steroids to decreased risk of asthma death; Connection of short-acting beta-antagonists to increasing risk of death; Importance of educating patients about the specific effects of inhalers on...

  • Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled BETA2 agonist. Fitzpatrick, M.F.; Mackay, T.; Driver, H.; Douglas, N.J. // BMJ: British Medical Journal (International Edition);12/15/90, Vol. 301 Issue 6765, p1365 

    Examines the efficacy of salmeterol in reducing bronchoconstriction in patients with nocturnal asthma in Edinburgh, Scotland. Measurement of asthma improvement by peak expiratory flow rates; Identification of sleep quality changes by electroencephalography; Severity of bronchoconstriction at...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics